Oxidative stress in young subjects with acute myocardial infarction: Evaluation at the initial stage and after 12 months

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 4, 2008, Pages 421-427

  LoPresti, Rosalia ^a   Catania, Anna ^a   D'Amico, Teresa ^a   Montana, Maria ^a   Caruso, Marco ^a   Caimi, Gregorio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Acute myocardial infarction in young people; Lipid peroxidation; Nitric oxide; Oxidative status

Indexed keywords

ANTIOXIDANT; NITRATE; NITRIC OXIDE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK ASSESSMENT;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE; OXIDATIVE STRESS; RISK FACTORS; TIME FACTORS;

EID: 51849097420     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607308406     Document Type: Article

References (43)

1. Karmansky A., Shnaider H., Palant A., Gruener N. Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease. Clin Biochem. 1996 ; 29: 573-579.
2. Kostner K., Hornykewycz S., Yang P., et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched control. Cardiovasc Res. 1997 ; 36: 330-336.
3. Doǧru-Abbasoǧlu S., Kanbaǧli Ö., Bulur H., et al. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem. 1999 ; 32: 671-672.
4. Nojiri S., Daida H., Mokuno H., et al. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J. 2001 ; 42: 677-690.
5. Kovacs IB, Jahangiri M., Rees GM, Görög P. Elevated plasma lipid hydroperoxides in patients with coronary artery disease. Am Heart J. 1997 ; 134: 572-576.
6. Tosukhowong P., Sangwatanaroj S., Jatuporn S., et al. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Clin Hemorheol Microcirc. 2003 ; 29: 321-329.
7. Mutlu-Türkoǧlu Ü., Akalin Z., İlhan. E., et al. Increased plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in patients with angiographically defined coronary artery disease. Clin Biochem. 2005 ; 38: 1059-1065.
8. Serdar Z., Aslan K., Dirican M., Sarandöl E., Yeşilbursa D., Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem. 2006 ; 39: 794-803.
9. Iqbal K., Rauoof MA, Mir MM, et al. Lipid peroxidation during acute coronary syndromes and its intensification at the time of myocardial ischemia reperfusion. Am J Cardiol. 2002 ; 89: 334-337.
10. Nikolic-Heitzler V., Rabuzin F., Tatzber F., et al. Persistent oxidative stress after myocardial infarction treated by percutaneous coronary intervention. Tohoku J Exp Med. 2006 ; 210: 247-255.
11. Senthil S., Veerappan RM, Ramakrishna Rao M., Pugalendi KV Oxidative stress and antioxidants in patients with cardiogenic shock complicating acute myocardial infarction. Clin Chim Acta. 2004 ; 348: 131-137.
12. Özmen D., Boydak B., Mutaf I., et al. The state of lipid peroxidation and antioxidants following thrombolytic therapy with rt-PA and streptokinase in acute myocardial infarction. Jpn Heart J. 1999 ; 40: 267-273.
13. Walter MF, Jacob RF, Jeffers B., et al. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol. 2004 ; 44: 1996-2002.
14. Durak I., Kacmaz M., Cimen MY, Buyukkocak U., Ozturk HS Blood oxidant/antioxidant status of atherosclerotic patients. Int J Cardiol. 2001 ; 77: 293-297.
15. Markovic S., Dordevic J., Majkic-Singh N., et al. The importance of antioxidant enzyme and total antioxidant status in patients with acute myocardial infarction on thrombolytic therapy. Clin Lab. 2000 ; 46: 495-499.
16. Fazendas P., Joao IF, Llobet S., et al. Plasma total antioxidant status in young survivors of myocardial infarction. Rev Portug Cardiol. 2000 ; 19: 463-467.
17. Yao D., Vlessidis AG, Evmiridis NP, Siminelakis S., Dimitra N. Possible mechanism for nitric oxide and oxidative stress induced pathophysiological variance in acute myocardial infarction development. A study by a flow injection-chemiluminescence method. Anal Chim Acta. 2004 ; 505: 115-123.
18. Vassalle C., Petrozzi L., Botto N., Andreassi MG, Zucchelli GC Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med. 2004 ; 256: 308-315.
19. Matsubara T., Ishibashi T., Hori T., et al. Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries. Mol Cell Biochem. 2003 ; 249: 67-73.
20. Wildhirt SM, Dudek RR, Suzuki H., Bing RJ Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol. 1995 ; 50: 253-261.
21. Akiyama K., Suzuki H., Grant P., Bing RJ Oxidant products of nitric oxide, NO2 and NO3, in plasma after experimental myocardial infarction. J Mol Cell Cardiol. 1997 ; 29: 1-9.
22. Liu Z.-Q., Wildhirt SM, Zhou H.-H. Specificity of inducible intric-oxide synthase inhibitors: prospects for their clinical therapy. Acta Pharmacol Sin. 1999 ; 20: 1052-1056.
23. Akiyama K., Kimura A., Suzuki H., et al. Production of oxidative products of nitric oxide in infarcted human heart. J Am Coll Cardiol. 1998 ; 32: 373-379.
24. Surekha RH, Srikanth Bbmv, Jharna P., Ramachandra RV, Dayasagar RV, Jyothy A. Oxidative stress and total antioxidant status in myocardial infarction. Singapore Med J. 2007 ; 48: 137-142.
25. Di Massimo C., Scarpelli P., Di Lorenzo N., Caimi G., Di Orio F., Tozzi-Ciancarelli MG Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci 2006 ; 78: 1163-1167.
26. Miller NJ, Rice-Evans C., Davies MJ, Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993 ; 84: 407-412.
27. Nims RW, Darbyshire JF, Saavedra JE, et al. Colorimetric methods for the determination of nitric oxide concentration in neutral aqueous solutions. Methods. 1995 ; 7: 48-54.
28. Fuji H., Shimizu M., Hidekazu I., et al. Oxidative stress correlates with left ventricular volume after acute myocardial infarction. Jpn Heart J. 2002 ; 43: 203-209.
29. Liu YH, Carretero OA, Cingolani OH, et al. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. Am J Physiol Heart Circ Physiol. 2005 ; 289: H2616 - H2623.
30. Ceriello A., Taboga C., Tonutti L., et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment. Circulation. 2002 ; 106: 1211-1218.
31. Marketou ME, Zacharis EA, Nikitovic D., et al. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. Angiology. 2006 ; 57: 211-218.
32. Orem C., Orem A., Uydu HA, Celik S., Erdol C., Kural BV The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status. Coron Artery Dis. 2002 ; 13: 65-71.
33. Thomas MK, Narang D., Lakshmy R., Gupta R., Naik N., Maulik SK Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients "on" and "off" atorvastatin for short time intervals. Cardiovasc Drugs Ther. 2006 ; 20: 37-44.
34. Resch U., Tatzber F., Budinsky A., Sinzinger H. Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy. Br J Clin Pharmacol. 2006 ; 61: 262-274.
35. Candore G., Balistreri CR, Lio D., et al. Association between HFE mutations and acute myocardial infarction: a study in patients from Northern and Southern Italy. Blood Cells Mol Dis. 2003 ; 31: 57-62.
36. Listì F., Candore G., Lio D., et al. Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur J Immunogenet. 2004 ; 31: 175-178.
37. Lio D., Candore G., Crivello A., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet. 2004 ; 41: 790-794.
38. Listì F., Candore G., Lio D., et al. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol. 2005 ; 102: 269-271.
39. Grimaldi MP, Candore G., Vasto S., et al. Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol. 2006 ; 79: 611-615.
40. Gasparetto C., Malinverno A., Culacciati D., et al. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Pharmacol. 2005 ; 18: 487-496.
41. Yesilbursa D., Serdar A., Senturk T., Serdar Z., Sag S., Cordan J. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction. Heart Vessels. 2006 ; 21: 33-37.
42. Tsujita K., Shimomura H., Kaikita K., et al. Long-term efficacy of edavarone in patients with acute myocardial infarction. Circ J. 2006 ; 70: 832-837.
43. Bhakuni P., Chandra M., Misra MK Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post reperfusion patients of myocardial infarction. Mol Cell Biochem. 2006 ; 290: 153-158.